Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
For T cells, HSV-2 infection is both a marathon and a sprint
From the Lund Lab, Vaccine and Infectious Disease Division
The Dos and Don’ts of designing peptide HLA-I single-chain trimers
From the Strong Lab, Basic Sciences and Vaccine and Infectious Disease Divisions
Dr. Philip Greenberg elected to National Academy of Sciences
Fred Hutch expert in immunology has led development of T-cell therapies for cancer
Decoding the function of clonally expanded T cells in kidney cancer
From the Warren Lab, Clinical Research Division
Vaginal immune mediators ramp up after first sexual intercourse
From the Hladik and Roxby labs, Vaccine and Infectious Disease Division
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Researchers pinpoint 'correlates of protection' for Moderna vaccine
Findings may make it easier to test COVID-19 vaccine updates to protect against variants
Neutralizing the foe: tracking the immune response to SARS-CoV-2 infection
From the Bloom Lab, Basic Sciences Division
What's with the spikes?
Those structures that give coronavirus its name might be SARS-CoV-2’s weak point
Fred Hutch research a GeekWire Award finalist for Health Innovation of the Year
Other finalists include Fred Hutch spinoffs Adaptive Biotechnologies and Blaze Bioscience
Dr. Philip Greenberg elected a Distinguished Fellow of the American Association of Immunologists
He is among 52 immunologists selected for the AAI 2019 inaugural class of fellows, including 5 Nobel laureates
Drs. Fred Appelbaum and Phil Greenberg elected to AACR Academy
They are among 22 scientists from around the world to join the 2019 class of Fellows
Fred Hutch collaborates with new Allen Institute for Immunology
Multi-collaborator initiative aims to map the immune system in health and disease
Improving cancer vaccines with T-cell programming nanoparticles
Dr. Matthias Stephan receives grant to develop cancer vaccine–optimizing, TCR-programming nanotechnology
The legacy of a pioneering transplant immunologist
‘So much to be learned’: Dr. John Hansen reflects on the lives he’s saved and the answers still to come
Double trouble: epithelial and B cell neutralization of Epstein-Barr virus
McGuire Laboratory, Vaccine and Infectious Disease Division
MAIT cells get around
From the Prlic Laboratory, Vaccine and Infectious Disease Division
First human antibody found to block Epstein-Barr virus
Early research could open new path for vaccine against EBV-related cancers, mononucleosis